Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Russia Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20042
20052
20062
20073
20083
20091
20102
20111
20133
20143
20151
20181
20212
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated6
Unknown status3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Meshalkin Research Institute of Pathology of Circulation7
Sanofi5
Boehringer Ingelheim3
Bristol-Myers Squibb2
Daiichi Sankyo2
Solvay Pharmaceuticals2
AstraZeneca1
Bayer1
CSL Behring1
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation29
Stroke6
Atrial Flutter4
Arrhythmias, Cardiac2
Coronary Artery Disease2
Embolism2
Heart Diseases2
Heart Valve Diseases2
Hypertension2
Acute Coronary Syndrome1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.